keyword
https://read.qxmd.com/read/38652012/natural-killer-cell-subsets-and-their-functional-molecules-in-peripheral-blood-of-the-patients-with-breast-cancer
#1
JOURNAL ARTICLE
Reza Darvishvand, Somayeh Rezaeifard, Razie Kiani, Sedigheh Tahmasebi, Zahra Faghih, Nasrollah Erfani
BACKGROUND: Natural killer (NK) cells, CD3- lymphocytes, are critical players in cancer immune surveillance. This study aimed to assess two types of CD3- NK cell classifications (subsets), that is, convectional subsets (based on CD56 and CD16 expression) and new subsets (based on CD56, CD27, and CD11b expression), and their functional molecules in the peripheral blood of patients with breast cancer (BC) in comparison with healthy donors (HDs). METHODS: Thirty untreated females with BC and 20 age-matched healthy women were enrolled...
April 2024: Immunity, Inflammation and Disease
https://read.qxmd.com/read/38651452/post-transplant-cyclophosphamide-versus-anti-thymocyte-globulin-in-patients-with-hematological-malignancies-treated-with-allogeneic-hematopoietic-stem-cell-transplantation-from-haploidentical-and-matched-unrelated-donors-a-real-life-experience
#2
JOURNAL ARTICLE
Bianca Serio, Gabriella Storti, Matteo D'Addona, Lidia Santoro, Camilla Frieri, Danilo De Novellis, Luana Marano, Giovanna De Santis, Roberto Guariglia, Ilenia Manfra, Eleonora Urciuoli, Serena Luponio, Serena Marotta, Denise Morini, Michela Rizzo, Fausto Palmieri, Nicola Cantore, Valentina Giudice, Antonio Maria Risitano, Carmine Selleri
Background: Post-transplant cyclophosphamide (PTCY) is widely used as graft versus host disease (GvHD) prophylaxis in allogeneic hematopoietic stem cell transplant (HSCT) recipients, with reported clinical benefits in patients who underwent transplant from a matched unrelated donor (MUD). However, real-life data on clinical efficacy and safety of PTCY in haploidentical and MUD transplantations are still poor. Methods: In our real-life retrospective observational study, we included a total of 40 consecutive adult patients who underwent haploidentical or MUD HSCT for various hematological malignancies and who received PTCY ( n = 24) or ATG ( n = 16) as GvHD prophylaxis at Hematology Units from hospitals of Salerno and Avellino, Italy, and clinical outcomes were compared...
April 17, 2024: Hematology Reports
https://read.qxmd.com/read/38651129/discussion-on-the-recruitment-strategy-for-apheresis-platelet-donors-in-chongqing-during-a-public-health-emergency
#3
JOURNAL ARTICLE
Ying Cheng, Chengbing Xie, Yunbo Tian, Fang Wang, Xingchen Liu, Danfeng Cheng
OBJECTIVE: This study aimed to analyze the population characteristics of apheresis platelet donors in Chongqing Province and provide a scientific basis for the development of precise and efficient recruitment strategies. The ultimate goal is to increase the number of regular platelet donors in preparation for public health emergencies. METHODS: This study involved 53,089 blood donors who donated apheresis platelets to the Chongqing Blood Center from 2020 to 2022...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38650381/absence-of-evidence-of-transfusion-transmission-risk-of-creutzfeldt-jakob-disease-in-the-united-states-results-froma-28-year-lookback-study
#4
JOURNAL ARTICLE
Lauren A Crowder, Roger Y Dodd, Lawrence B Schonberger
BACKGROUND: For many years, there has been concern about the risk of transmission of classic forms of Creutzfeldt-Jakob disease (CJD) by blood transfusion, particularly after the recognition of such transmission of variant CJD (vCJD). We report on a 28-year lookback study of recipients of blood from donors who subsequently developed CJD. METHODS: Patients with diagnosed CJD and a history of blood donation were identified. Blood centers were asked to provide information about the distribution of the donations and consignees were requested to provide information about the recipients of the donations...
April 22, 2024: Transfusion
https://read.qxmd.com/read/38650378/how-do-we-leverage-data-through-replication-and-warehousing-to-meet-blood-collection-and-transfusion-service-needs
#5
Justin E Juskewitch, Lynne Briggs, Jenna Khan, Patrick C Mathias, Terri S Coyle, Vicki L Courson, James T Hansen, Nageswar Madde, Mandy F O'Leary, Hamilton C Tsang
BACKGROUND: With the widespread adoption of Blood Establishment Computer Systems and other Blood Collection and Transfusion Service (BCTS) clinical information systems (CIS), electronic blood donor, product, and patient data are now routinely required for clinical, regulatory, operational, and quality needs. That data are often not readily accessible for such secondary use within CIS databases, particularly for applications with significant data availability requirements such as machine learning and artificial intelligence...
April 22, 2024: Transfusion
https://read.qxmd.com/read/38649419/mir-451a-was-selectively-sorted-into-exosomes-and-promoted-the-progression-of-esophageal-squamous-cell-carcinoma-through-cab39
#6
JOURNAL ARTICLE
Lu Wang, Huijuan Liu, Qinglu Wu, Yiqian Liu, Zhenpeng Yan, Guohui Chen, Yao Shang, Songrui Xu, Qichao Zhou, Ting Yan, Xiaolong Cheng
Exosomes are emerging mediators of cell-cell communication, which are secreted from cells and may be delivered into recipient cells in cell biological processes. Here, we examined microRNA (miRNA) expression in esophageal squamous cell carcinoma (ESCC) cells. We performed miRNA sequencing in exosomes and cells of KYSE150 and KYSE450 cell lines. Among these differentially expressed miRNAs, 20 of the miRNAs were detected in cells and exosomes. A heat map indicated that the level of miR-451a was higher in exosomes than in ESCC cells...
April 22, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38649146/vstm2l-is-a-promising-therapeutic-target-and-a-prognostic-soluble-biomarker-in-cholangiocarcinoma
#7
Jungwhoi Lee, Woogwang Sim, Jungsul Lee, Jae-Hoon Kim
The aim of the present study is to provide a rational background for silencing the V-set and transmembrane domain containing 2 like (VSTM2L) in consort with recognising soluble VSTM2L against cholangiocarcinoma. A therapeutic target against cholangiocarcinoma was selected using iterative patient partitioning (IPP) calculation, and it was verified by in vitro and in silico analyses. VSTM2L was selected as a potential therapeutic target against cholangiocarcinoma. Silencing the VSTM2L expression significantly attenuated the viability and survival of cholangiocarcinoma cells through blockade of the intracellular signalling pathway...
April 23, 2024: BMB Reports
https://read.qxmd.com/read/38648768/human-blood-serum-counteracts-egfr-her2-targeted-drug-lapatinib-impact-on-squamous-carcinoma-sk-br-3-cell-growth-and-gene-expression
#8
JOURNAL ARTICLE
Nina Shaban, Mikhail Raevskiy, Galina Zakharova, Victoria Shipunova, Sergey Deyev, Maria Suntsova, Maksim Sorokin, Anton Buzdin, Dmitri Kamashev
Lapatinib is a targeted therapeutic inhibiting HER2 and EGFR proteins. It is used for the therapy of HER2-positive breast cancer, although not all the patients respond to it. Using human blood serum samples from 14 female donors (separately taken or combined), we found that human blood serum dramatically abolishes the lapatinib-mediated inhibition of growth of the human breast squamous carcinoma SK-BR-3 cell line. This antagonism between lapatinib and human serum was associated with cancelation of the drug induced G1/S cell cycle transition arrest...
March 2024: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38647039/the-prevalence-of-human-immunodeficiency-virus-infection-among-voluntary-blood-donors-in-mainland-china-a-systematic-review-and-meta-analysis
#9
JOURNAL ARTICLE
Yuhui Li, Xinhui Zhang, Yang Huang, Lei Gao, Zhan Gao, Miao He
Human immunodeficiency virus (HIV) infection through transfusion has been an imperative challenge for blood safety. Despite the implementation of screening strategies, there was still the residual risk of transfusion-transmitted HIV. Considering that the prevalence of HIV infection in blood donors is significant for evaluating blood safety and potential risks to the population, meta-analysis was applied to investigate the HIV prevalence among voluntary blood donors during the past 27 years to characterize the epidemiology and related risk factors of HIV in blood donors...
April 2024: Journal of Medical Virology
https://read.qxmd.com/read/38646695/immune-reconstitution-in-children-after-haploidentical-haematopoietic-stem-cell-transplantation
#10
JOURNAL ARTICLE
Saranthorn Apasuthirat, Nopporn Apiwattanakul, Usanarat Anurathapan, Nintita Sripaiboonkij Thokanit, Karan Paisooksantivatana, Ekawat Pasomsub, Suradej Hongeng, Samart Pakakasama
INTRODUCTION: Immune reconstitution (IR) kinetics of paediatric patients underwent haploidentical haematopoietic stem cell transplantation (HSCT) with post-transplant cyclophosphamide (PTCy) have not been extensively studied. We compared IR patterns of children receiving HSCT from haploidentical (n = 92) and HLA-matched donors (n = 36), and analysed risk factors for viral infection in these patients. METHODS: We prospectively measured lymphocyte subset numbers before HSCT and at 1, 3, 6 and 12 months after HSCT...
April 22, 2024: International Journal of Laboratory Hematology
https://read.qxmd.com/read/38646525/memory-b-cell-derived-donor-specific-antibodies-do-not-predict-outcome-in-sensitized-kidney-transplant-recipients-a-retrospective-single-center-study
#11
JOURNAL ARTICLE
Dania Altulea, Joost C van den Born, Arjan Diepstra, Laura Bungener, Dagmar Terpstra, Bouke G Hepkema, Rosa Lammerts, Peter Heeringa, Sebastiaan Heidt, Henny Otten, Leon Reteig, Gonca E Karahan, Stefan P Berger, Jan-Stephan Sanders
BACKGROUND: Repeated exposure to sensitizing events can activate HLA-specific memory B cells, leading to the production of donor-specific memory B cell antibodies (DSAm) that pose a risk for antibody-mediated rejection (ABMR) in kidney transplant recipients (KTRs). This single-center retrospective study aimed to identify DSAm and assess their association with outcomes in a cohort of KTRs with pretransplant serum donor-specific antibodies (DSA). METHODS: We polyclonally activated pretransplant peripheral blood mononuclear cells (PBMCs) from 60 KTRs in vitro, isolated and quantified IgG from the culture supernatant using ELISA, and analyzed the HLA antibodies of eluates with single antigen bead (SAB) assays, comparing them to the donor HLA typing for potential DSAm...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38646314/necrotizing-enterocolitis-in-an-infant-with-a-history-of-twin-twin-transfusion-syndrome-a-case-report
#12
Nga N Tran, Sydney Hutto, James Liu, Tyler Bullock, Richard Virgilio, David L Flowers
This case report describes necrotizing enterocolitis (NEC) in an infant with a history of twin-twin transfusion syndrome (TTTS). TTTS is a volume imbalance where the anastomosis at the vascular equator between the two placentae shifts from the donor to the recipient twin. This causes a higher risk for NEC, a marked inflammation caused by bacterial infection into the intestinal wall, from prematurity and intestinal hypoperfusion. Complications include sepsis, bowel necrosis, perforation, peritonitis, and death...
March 2024: Curēus
https://read.qxmd.com/read/38645784/recent-advancements-in-hematopoietic-stem-cell-transplantation-in-taiwan
#13
REVIEW
Chi-Cheng Li, Xavier Cheng-Hong Tsai, Wei-Han Huang, Tso-Fu Wang
Hematopoietic stem cell transplantation (HSCT) can cure malignant and nonmalignant hematological disorders. From 1983 to 2022, Taiwan performed more than 10,000 HSCT transplants. The Taiwan Blood and Marrow Transplantation Registry collects clinical information to gather everyone's experience and promote the advances of HSCT in Taiwan to gather everyone's experience and promote advances of HSCT in Taiwan. Compared with matched sibling donors, transplants from matched unrelated donors exhibited a trend of superior survival...
2024: Tzu chi medical journal
https://read.qxmd.com/read/38645783/association-of-hla-c-07-359-with-hla-a-b-and-drb1-alleles-in-taiwanese
#14
JOURNAL ARTICLE
Kuo-Liang Yang, Py-Yu Lin
OBJECTIVES: It is thought that Taiwanese indigenous people were the "first people" to populate Taiwan (Formosa) having been there for over 5000 years, preceding the Dutch colonization (from 1624 to 1662) and Spanish colonization (from 1626 to 1642). Taiwan's indigenes, represented by Austronesian language speakers, currently constitute approximately 2% of the total population in Taiwan. It is unknown whether they evolved from Taiwan's Paleolithic or Neolithic cultures, arrived during or after the Neolithic period from China or Southeast Asia or both...
2024: Tzu chi medical journal
https://read.qxmd.com/read/38645553/corrigendum-an-in-vitro-study-to-elucidate-the-effects-of-product-nkabinde-on-immune-response-in-peripheral-blood-mononuclear-cells-of-healthy-donors
#15
Boitumelo Setlhare, Marothi Letsoalo, Siphathimandla Authority Nkabinde, Magugu Nkabinde, Gugulethu Mzobe, Andile Mtshali, Sobia Parveen, Samukelisiwe Ngcobo, Luke Invernizzi, Vinesh Maharaj, Mlungisi Ngcobo, Nceba Gqaleni
[This corrects the article DOI: 10.3389/fphar.2024.1308913.].
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38644197/carbon-monoxide-alleviates-post-ischemia-reperfusion-skeletal-muscle-injury-and-systemic-inflammation
#16
JOURNAL ARTICLE
Kazuaki Taguchi, Shigeru Ogaki, Hitoshi Maeda, Yu Ishima, Hiroshi Watanabe, Masaki Otagiri, Toru Maruyama
Restoration of blood flow in skeletal muscle after a prolonged period of ischemia induces muscular ischemia-reperfusion injury, leading to local injury/dysfunction in muscles followed by systemic inflammatory responses. However, preventive/curative agents for skeletal muscle ischemia injury are unavailable in clinics to date. Increasing evidence has validated that carbon monoxide (CO) prevents the progression of ischemia-reperfusion injury in various organs owing to its versatile bioactivity. Previously, we developed a bioinspired CO donor, CO-bound red blood cells (CO-RBC), which mimics the dynamics of RBC-associated CO in the body...
2024: Biological & Pharmaceutical Bulletin
https://read.qxmd.com/read/38643958/persistent-or-new-cytopenias-predict-relapse-better-than-routine-bone-marrow-aspirate-evaluations-after-hematopoietic-cell-transplantation-for-acute-leukemia-or-myelodysplastic-syndrome-in-children-and-young-adult-patients
#17
JOURNAL ARTICLE
Nancy A Kernan, Elizabeth Klein, Audrey Mauguen, Joanne Torok-Castanza, Susan E Prockop, Andromachi Scaradavou, Kevin Curran, Barbara Spitzer, Maria Cancio, Julie Ruggiero, Jennifer Allen, Andrew Harris, Joseph Oved, Richard J O'Reilly, Jaap Jan Boelens
BACKGROUND: The clinical value of serial routine bone marrow aspirates (rBMAs) in the first year after allogeneic hematopoietic cell transplantation (alloHCT) to detect or predict relapse of acute leukemia (AL) and myelodysplastic syndrome (MDS) in pediatric and young adult patients is unclear. OBJECTIVE: The purpose of this analysis was to determine if assessment of minimal residual disease (MRD) by multiparameter flow cytometry (MFC, MFC-MRD) or donor chimerism (DC) in rBMAs or serial CBCs done in the year after alloHCT predicted relapse of AL or MDS in pediatric and young adult patients...
April 20, 2024: Transplantation and cellular therapy
https://read.qxmd.com/read/38643511/alternative-donor-transplantation-for-severe-aplastic-anemia-a-comparative-study-of-the-saawp-ebmt
#18
JOURNAL ARTICLE
Juan Montoro, Diderik-Jan Eikema, Joe Tuffnell, Victoria Potter, Krzysztof Kałwak, Constantijn Jm Jm Halkes, Alexander Kulagin, Matthew Collin, Robert F Wynn, Stephen Robinson, Emma Nicholson, Henrik Sengeloev, Khalid Halahleh, Elena Skorobogatova, Jaime Sanz, Jakob R Passweg, Stephan Mielke, Samppa Johannes Ryhänen, Ben Carpenter, Tobias Gedde-Dahl, Eleni Tholouli, Renato Fanin, Philippe Lewalle, Austin G Kulasekararaj, Antonio Maria Risitano, Régis Peffault de Latour
Selecting the most suitable alternative donor becomes challenging in severe aplastic anemia (SAA) when a matched sibling donor (MSD) is unavailable. We compared outcomes in SAA patients undergoing SCT from matched unrelated donors (MUD, n=1106), mismatched unrelated donors (MMUD, n=340), and haploidentical donors (Haplo, n=206) registered in the EBMT database (2012-2021). For Haplo-SCT, only those receiving post-transplant cyclophosphamide (PT-Cy) for graft-versus-host disease (GVHD) prophylaxis were included...
April 21, 2024: Blood
https://read.qxmd.com/read/38643027/arbovirus-a-threat-to-transfusion-safety-in-spain-a-narrative-review
#19
REVIEW
Ángel Giménez-Richarte, Cristina Arbona Castaño, José-Manuel Ramos-Rincón
Arboviruses represent a threat to transfusion safety for several reasons: the presence of vectors and the notification of autochthonous cases in our region, the recent increase in the number of cases transmitted through blood and/or blood component transfusion, the high prevalence rates of RNA of the main arboviruses in asymptomatic blood donors, and their ability to survive processing and storage in the different blood components. In an epidemic outbreak caused by an arbovirus in our region, transfusion centres can apply different measures: reactive measures, related to donor selection or arbovirus screening, and proactive measures, such as pathogen inactivation methods...
April 19, 2024: Medicina Clínica
https://read.qxmd.com/read/38642579/neuropilin-2-and-soluble-neuropilin-2-in-neuroendocrine-neoplasms
#20
JOURNAL ARTICLE
Laura Gerard, Céline Patte, Laurence Chardon, Valerie Hervieu, Léa Payen, Marion Allio, Claire Marx, Hugo Clermidy, Alice Durand, Patrick Mehlen, Julien Bollard, Gilles Poncet, Colette Roche, Benjamin Gibert, Thomas Walter
Neuropilin-2 (NRP2), a transmembrane non-tyrosine kinase receptor, has been described as a potential critical player in the tumourigenesis of several solid cancers, and particularly in neuroendocrine neoplasms (NEN). A soluble form of NRP2 (sNRP2) has been previously described and corresponds to a truncated splice isoform. Its prognostic value has never been studied in NEN. NRP2 expression was studied by immunochemistry on tissue microarrays (n=437) and on circulating tumour cells (CTC, n=5 patients with neuroendocrine carcinoma, NEC)...
April 1, 2024: Endocrine-related Cancer
keyword
keyword
40992
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.